Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Pozycja w akcjach #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Cena akcji
$0.0001
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$150.00
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Poniard Pharmaceuticals, Inc. (PARD)

Kategoria

Historia ceny akcji dla Poniard Pharmaceuticals, Inc. (PARD)
Najwyższa cena zamknięcia: $0.00 dnia 2026-08-01

Najniższa cena zamknięcia: $1.69K dnia 1988-08-01
Historia cen akcji firmy Poniard Pharmaceuticals, Inc. od 1988 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -99.00%
2022 0.00%
2021 -73.59%
2020 68.39%
2019 -58.15%
2018 0.25%
2017 -41.00%
2016 2.48%
2015 -45.77%
2014 -26.13%
2013 -32.03%
2012 -90.08%
2011 -82.25%
2010 -77.28%
2009 282.90%
2008 -55.38%
2007 -20.51%
2006 12.16%
2005 -57.29%
2004 -54.54%
2003 688.74%
2002 -88.91%
2001 -12.65%
2000 77.36%
1999 162.56%
1998 -76.29%
1997 24.18%
1996 -29.30%
1995 19.35%
1994 -39.86%
1993 -35.31%
1992 -11.37%
1991 687.42%
1990 -85.32%
1989 -41.53%
1988 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -7.22%
KR